BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18411288)

  • 1. Nasal vaccination with the 40-kilodalton outer membrane protein of Porphyromonas gingivalis and a nontoxic chimeric enterotoxin adjuvant induces long-term protective immunity with reduced levels of immunoglobulin E antibodies.
    Momoi F; Hashizume T; Kurita-Ochiai T; Yuki Y; Kiyono H; Yamamoto M
    Infect Immun; 2008 Jun; 76(6):2777-84. PubMed ID: 18411288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal immunization with the 40-kDa outer membrane protein of Porphyromonas gingivalis plus cholera toxin induces protective immunity in aged mice.
    Cai Y; Kurita-Ochiai T; Kobayashi R; Hashizume T; Yamamoto M
    J Oral Sci; 2013; 55(2):107-14. PubMed ID: 23748449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcutaneous immunization with a 40-kDa outer membrane protein of Porphyromonas gingivalis induces specific antibodies which inhibit coaggregation by P. gingivalis.
    Maeba S; Otake S; Namikoshi J; Shibata Y; Hayakawa M; Abiko Y; Yamamoto M
    Vaccine; 2005 Mar; 23(19):2513-21. PubMed ID: 15752838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublingual vaccination with outer membrane protein of Porphyromonas gingivalis and Flt3 ligand elicits protective immunity in the oral cavity.
    Zhang T; Hashizume T; Kurita-Ochiai T; Yamamoto M
    Biochem Biophys Res Commun; 2009 Dec; 390(3):937-41. PubMed ID: 19852927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific antibodies induced by nasally administered 40-kDa outer membrane protein of Porphyromonas gingivalis inhibits coaggregation activity of P. gingivalis.
    Namikoshi J; Otake S; Maeba S; Hayakawa M; Abiko Y; Yamamoto M
    Vaccine; 2003 Dec; 22(2):250-6. PubMed ID: 14615153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcutaneous immunization with an outer membrane protein of Porphyromonas gingivalis without adjuvant elicits marked antibody responses.
    Koizumi Y; Kurita-Ochiai T; Yamamoto M
    Oral Microbiol Immunol; 2008 Apr; 23(2):131-8. PubMed ID: 18279181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral immunization with Porphyromonas gingivalis outer membrane protein and CpGoligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective immunity.
    Liu C; Hashizume T; Kurita-Ochiai T; Fujihashi K; Yamamoto M
    Mol Oral Microbiol; 2010 Jun; 25(3):178-89. PubMed ID: 20502628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice.
    Koizumi Y; Kurita-Ochiai T; Oguchi S; Yamamoto M
    Infect Immun; 2008 Jul; 76(7):2958-65. PubMed ID: 18426881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal immunization with a fusion protein consisting of the hemagglutinin A antigenic region and the maltose-binding protein elicits CD11c(+) CD8(+) dendritic cells for induced long-term protective immunity.
    Du Y; Hashizume T; Kurita-Ochiai T; Yuzawa S; Abiko Y; Yamamoto M
    Infect Immun; 2011 Feb; 79(2):895-904. PubMed ID: 21115722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies.
    Kweon MN; Yamamoto M; Watanabe F; Tamura S; Van Ginkel FW; Miyauchi A; Takagi H; Takeda Y; Hamabata T; Fujihashi K; McGhee JR; Kiyono H
    J Infect Dis; 2002 Nov; 186(9):1261-9. PubMed ID: 12402195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
    Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
    Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal immunization with a flagellin-adjuvanted Hgp44 vaccine enhances protective immune responses in a murine Porphyromonas gingivalis infection model.
    Puth S; Hong SH; Park MJ; Lee HH; Lee YS; Jeong K; Kang IC; Koh JT; Moon B; Park SC; Rhee JH; Lee SE
    Hum Vaccin Immunother; 2017 Dec; 13(12):2794-2803. PubMed ID: 28604268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory FimA-Specific Secretory IgA Antibodies Upregulated by DC-Targeting Nasal Double DNA Adjuvant Are Essential for Elimination of
    Kataoka K; Kawabata S; Koyanagi K; Hashimoto Y; Miyake T; Fujihashi K
    Front Immunol; 2021; 12():634923. PubMed ID: 33717178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The r40-kDa outer membrane protein human monoclonal antibody protects against Porphyromonas gingivalis-induced bone loss in rats.
    Hamada N; Watanabe K; Tahara T; Nakazawa K; Ishida I; Shibata Y; Kobayashi T; Yoshie H; Abiko Y; Umemoto T
    J Periodontol; 2007 May; 78(5):933-9. PubMed ID: 17470029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of outer membrane vesicles of periodontopathic bacterium Porphyromonas gingivalis as possible mucosal immunogen.
    Nakao R; Hasegawa H; Dongying B; Ohnishi M; Senpuku H
    Vaccine; 2016 Aug; 34(38):4626-4634. PubMed ID: 27461458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal vaccination shapes the expression of salivary antibodies and establishment of CD8+ T-cells.
    Polak D; Benzki-Namdar E; Houri-Haddad Y; Shapira L
    J Periodontol; 2014 Jul; 85(7):991-7. PubMed ID: 24359165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual vaccination with fusion protein consisting of the functional domain of hemagglutinin A of Porphyromonas gingivalis and Escherichia coli maltose-binding protein elicits protective immunity in the oral cavity.
    Yuzawa S; Kurita-Ochiai T; Hashizume T; Kobayashi R; Abiko Y; Yamamoto M
    FEMS Immunol Med Microbiol; 2012 Mar; 64(2):265-72. PubMed ID: 22066647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyromonas gingivalis-specific immunoglobulin G prevents P. gingivalis-elicited oral bone loss in a murine model.
    Gibson FC; Gonzalez DA; Wong J; Genco CA
    Infect Immun; 2004 Apr; 72(4):2408-11. PubMed ID: 15039370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses to Porphyromonas gingivalis hemagglutinin A and outer membrane protein in chronic periodontitis.
    Kobayashi T; Kaneko S; Tahara T; Hayakawa M; Abiko Y; Yoshie H
    J Periodontol; 2006 Mar; 77(3):364-9. PubMed ID: 16512750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host responses to recombinant hemagglutinin B of Porphyromonas gingivalis in an experimental rat model.
    Katz J; Black KP; Michalek SM
    Infect Immun; 1999 Sep; 67(9):4352-9. PubMed ID: 10456874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.